Elsevier's 2027 Intravenous Medications

di Shelly Rainforth Collins (Autore)

Elsevier Health Sciences, 2026

**Selected for 2026 Doody's Core Titles as an Essential Purchase in Medical/Surgical** Find the essential information you need to safely administer more than 400 intravenous drugs! The newest edition of a reference trusted for more than 50 years, Elsevier’s 2027 Intravenous Medications is a concise, quick-access guide to complete, accurate drug information. New to this edition are 10-20 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings. Detailed monographs on more than 400 IV drugs provide an impressive breadth of coverage that goes well beyond any comparable drug reference Convenient, A-to-Z format organizes all drug monographs by generic name, allowing you to find any drug in seconds Individual monographs include the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more 50-year history of impeccable accuracy reinforces the importance of safe IV drug administration Proven, clinically-optimized page layout keeps all dosage information for each drug on either a single page or a two-page spread to prevent hand contamination by having to turn a page Highlighted Black Box Warnings make it easy to locate information on medications with serious safety risks Blue-screened text calls attention to other circumstances not covered by Black Box Warnings Dosage and dilution charts within monographs provide quick summaries of essential clinical information Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients Additional drug monographs are provided on the companion Evolve website NEW! Drug monographs for approximately 10-20 newly approved drugs by the FDA include the most current information NEW! Updates with new interactions, precautions, alerts, drug uses, patient teaching instructions, and more are included throughout the guide to reflect changes and prevent medication dispensing errors NEW! QR codes for additional drug monographs enable quick access at the point of care

• Autore: Shelly Rainforth Collins
• Editore: Elsevier Health Sciences
• Anno: 2026
• Rilegatura: Spiral bound
• Pagine: 1344 p.
• Dimensioni: 229 x 152 mm
• Peso: 450 gr.
• EAN: 9780443433368

Testo in English